The number of organ transplantations is increasing every year.
In 2011, more than 30,000 transplants took place in the European Union (EU) alone.1
Astellas is among the global leaders in transplantation, providing immunosuppressant treatments for solid organ transplants such as kidney, liver and heart. Astellas will continue playing a key role in the care of transplant patients. In future, we intend to expand our portfolio beyond immunosuppressant treatments and are currently investigating therapies for prevention of cytomegalovirus infections in transplant patients.